Circulation Reports
Online ISSN : 2434-0790
Exercise Physiology
Low Activities of Daily Living Associated With Increased Cardiovascular Disease Mortality in Japan ― Analysis of Health Records From a Nationwide Claim-Based Database, JROAD-DPC ―
Masaomi GohbaraKunihiro NishimuraMichikazu NakaiYoko SumitaTsutomu EndoYasushi MatsuzawaMasaaki KonishiMasami KosugeToshiaki EbinaKouichi TamuraKazuo Kimura
Author information
JOURNAL OPEN ACCESS FULL-TEXT HTML

2019 Volume 1 Issue 1 Pages 20-28

Details
Abstract

Background: The aim of this study was to clarify the clinical impact of activities of daily living (ADL) using the Japanese Registry of All Cardiac and Vascular Diseases-Diagnosis Procedure Combination (JROAD-DPC) database.

Methods and Results: From April 2012 to March 2014, the JROAD-DPC database included 206,643 patients with acute coronary syndrome (ACS; n=49,784), heart failure (HF; n=136,878), or aortic aneurysm/dissection (Aorta; n=19,981). We divided them into 3 categories with regard to age (low, 20–59 years; middle, 60–79 years; high, ≥80 years) and admission ADL (low, Barthel index [BI] 0–70; middle, BI 75–95; high, BI 100). ACS, HF, and Aorta patients with low ADL had higher in-hospital mortality rates (18.3%, 16.7%, and 33.4%) than those with middle or high ADL (P<0.001, χ2 test). On multivariable analysis, BI on admission was associated with in-hospital mortality of ACS (OR, 0.986 per 1 BI; P<0.001), HF (OR, 0.986 per 1 BI; P<0.001), and Aorta (OR, 0.986 per 1 BI; P<0.001), adjusted for gender, age, body mass index, hypertension, diabetes mellitus, dyslipidemia, and the Charlson comorbidity index. Moreover, patients with low age and low ADL had a higher in-hospital mortality rate than those with high age and high ADL in regard to HF (8.6% vs. 6.0%).

Conclusions: According to JROAD-DPC data, assessment of admission ADL is important in patients with cardiovascular disease.

Content from these authors
© 2019 THE JAPANESE CIRCULATION SOCIETY

This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
https://creativecommons.org/licenses/by-nc-nd/4.0/
Previous article Next article
feedback
Top